510(k) · Cleared
ClearedFoundation Porous Acetabular System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Encore Orthopedics, Inc. · LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented
Cleared on Jan 28, 1998 after a 161-day review. The FDA summary names no predicate by number. 142 later devices descend from it.
- Decided
- Jan 28, 1998
- Review
- 161 days
- Class
- Class II
- Product code
- LPH
- Recalls
- None
- Predicates
- 0
142 later devices descend from it, 7 citing it directly.
- This deviceK973119 Foundation Porous Acetabular SystemEncore Orthopedics, Inc. · 1998
- Descendant · cites it directly · 103 of its ownK072888 Revelation and Linear Hip Stems and FMP Acetabular Shells (Spiked…Encore Medical L.P. · 2008
- Descendant · 2 generations on · 74 of its ownK112069 RSP Glenoid Baseplate Porous CoatedEncore Medical L.P. · 2011 · Recalled
- Descendant · cites it directly · 61 of its ownK072154 Foundation (FMP) Porous Coated Spiked Acetabular SystemEncore Medical L.P. · 2007 · Recalled
- Descendant · 3 generations on · 55 of its ownK140904 RSP Monoblock Stem with P2 Coating, Size 6Encore Medical L.P. · 2014
- Descendant · 2 generations on · 38 of its ownK130365 X-Alt Highly Cross Linked VE Acetabular LinerEncore Medical L.P. · 2013
Showing 5 of 142 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 142 · See all- K072888Revelation and Linear Hip Stems and FMP Acetabular Shells (Spiked, Hemispherical and…Encore Medical L.P. · 2008 · cites it directly103descendants
- K112069RSP Glenoid Baseplate Porous CoatedEncore Medical L.P. · 2011 · 2 generations on74descendants
- K072154Foundation (FMP) Porous Coated Spiked Acetabular SystemEncore Medical L.P. · 2007 · cites it directly61descendants
- K140904RSP Monoblock Stem with P2 Coating, Size 6Encore Medical L.P. · 2014 · 3 generations on55descendants
- K130365X-Alt Highly Cross Linked VE Acetabular LinerEncore Medical L.P. · 2013 · 2 generations on38descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K973119 | Foundation Porous Acetabular System | Encore Orthopedics, Inc. | 1998 | — |
| +1 | K072888 | Revelation and Linear Hip Stems and FMP Acetabular Shells (Spiked… | Encore Medical L.P. | 2008 | — |
| +2 | K112069 | RSP Glenoid Baseplate Porous Coated | Encore Medical L.P. | 2011 | 1 |
| +1 | K072154 | Foundation (FMP) Porous Coated Spiked Acetabular System | Encore Medical L.P. | 2007 | 1 |
| +3 | K140904 | RSP Monoblock Stem with P2 Coating, Size 6 | Encore Medical L.P. | 2014 | — |
| +2 | K130365 | X-Alt Highly Cross Linked VE Acetabular Liner | Encore Medical L.P. | 2013 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 1 | 0 |
| 2012 | 2 | 0 |
| 2013 | 3 | 0 |
| 2014 | 12 | 0 |
| 2015 | 5 | 0 |
| 2016 | 6 | 0 |
| 2017 | 8 | 0 |
| 2018 | 7 | 0 |
| 2019 | 10 | 0 |
| 2020 | 9 | 0 |
| 2021 | 11 | 0 |
| 2022 | 13 | 0 |
| 2023 | 12 | 0 |
| 2024 | 10 | 0 |
| 2025 | 14 | 0 |
| 2026 | 15 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LPH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LPH device
- #1 K233498 Stryker Orthopaedics Hip Systems Labeling Updatescore 24.2 · 20 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
The FDA summary names no predicate by number.
What descends from it? (142)
See all 1427 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K072888 | Revelation and Linear Hip Stems and FMP Acetabular Shells (Spiked, Hemispherical and… | 2008 | 103 |
| K072154 | Foundation (FMP) Porous Coated Spiked Acetabular System | 2007 | 61 |
| K112158 | Modulus Stems, Modulus Necks, Modular Femoral Heads, Cemented Cups, Lock Bipolar Heads | 2012 | 13 |
| K112898 | Delta TT Cups, Delta TT Liners, Bone Screws | 2012 | 12 |
| K140130 | X-Alt Highly Cross Linked Acetabular Liners with Vitamin E, Neutral, 10 Degree Hooded… | 2014 | 1 |
| K092098 | Patient Specific Acetabular Reconstruction Prosthesis | 2010 | 1 |
| K191708 | Origin Stem, Evolve Stem, Aria Hip Stem, Remedy Stem, CoCr Femoral Head | 2020 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K072888 (Encore Medical L.P., 2008) has gone furthest, with 103 descendants of its own.
How does its category compare?
All LPH devicesLPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LPH
12in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LPH
153in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LPH
4in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LPH
6,163in 2025
MAUDE reports naming product code LPH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 116 | 16 | 509 |
| 2008 | 10 | 86 | 1 | 706 |
| 2009 | 3 | 112 | 2 | 1,156 |
| 2010 | 15 | 100 | 22 | 2,007 |
| 2011 | 16 | 110 | 26 | 3,320 |
| 2012 | 25 | 76 | 30 | 3,785 |
| 2013 | 11 | 135 | 9 | 5,002 |
| 2014 | 20 | 129 | 3 | 5,163 |
| 2015 | 18 | 111 | 1 | 5,830 |
| 2016 | 10 | 150 | 8 | 4,900 |
| 2017 | 12 | 121 | 14 | 5,312 |
| 2018 | 9 | 145 | 2 | 5,954 |
| 2019 | 22 | 164 | 8 | 7,130 |
| 2020 | 7 | 164 | 6 | 5,429 |
| 2021 | 8 | 410 | 4 | 5,978 |
| 2022 | 14 | 247 | 2 | 5,223 |
| 2023 | 10 | 111 | 2 | 5,345 |
| 2024 | 6 | 92 | 1 | 5,626 |
| 2025 | 12 | 153 | 4 | 6,163 |
| 2026 | 8 | 256 | 2 | — |
What is it indicated for?
The indications for use of the total hip replacement prosthesis include:
noninflammatory degenerative joint disease including osteoarthritis and
avascular necrosis; rheumatoid arthritis; correction of functional deformity;
ravieion procedures where other treatments where devices have failed; and
treatment of nonunion, femoral neck and trochanteric fractures of the
proximal femur with head involvement, which is unmanageable using other
techniques.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K973119 · printed Nov 5, 2026
Cite this page
510(k) Report. “K973119: Foundation Porous Acetabular System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K973119
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026